Book a FREE no obligation demo with one of our specialists to see how Plimsoll can help you
Book a free Demo
Abbott laboratories ltd
Registration Number
00329102Incorporation Date
23/06/1937Last Annual Return
Not availableAddress
Abbott House, Vanwall Business Park, Maidenhead, Berkshire. SL6 4XE
Website
www.abbottlaboratories.co.ukAudit Fees
£32,000Secretary
Mr Kevan Gogay
Directors
Active
Mr Ross Iain Campbell (49 yrs)
Active
Ms Alison Davies (57 yrs)
Active
Mr Michael Robert Kendall Clayton (51 yrs)
Active
Ms Camilla Maria Kruchov Soenderby (53 yrs)
| Proposed Year |
|||||
|---|---|---|---|---|---|
| Period Ending | 31-Dec-20 | 31-Dec-21 | 31-Dec-22 | 31-Dec-23 | 29-Dec-24 |
| Weeks | 52 | 52 | 52 | 52 | 52 |
| Total Sales (£000) | 394395 | 443189 | 479308 | 539543 | 620909 |
| Directors Fees | 927 | 1011 | 998 | 535 | 642 |
| Gross Profits | 105613 | 123941 | 120164 | 134184 | 154420 |
| Value Added | 90871 | 96880 | 100010 | 102819 | 343918 |
| Trading Profit | 24500 | 26100 | 32509 | 31754 | 269571 |
| Depreciation | 10484 | 12894 | 18050 | 15031 | |
| Non-Trading Income | 2862 | 2030 | 92800 | 175982 | 0 |
| Total Interest Charges | 444 | 475 | 1109 | 2530 | 3036 |
| Pre-tax Profit | 16434 | 14761 | 106150 | 190175 | 248498 |
| Retained Profit (Shareholders Funds) | 16178 | 259233 | 151862 | 35296 | 114105 |
| Fixed Assets | 59242 | 64790 | 89084 | 79914 | 95897 |
| Intangibles | 0 | 384 | 2796 | 11863 | 14236 |
| Intermediate Assets | 221163 | 573763 | 757163 | 793563 | 952276 |
| Stocks | 22076 | 29329 | 23696 | 28268 | 32531 |
| Debtors | 74669 | 89142 | 83474 | 101413 | 116707 |
| Cash or Equivalent | 72859 | 44561 | 75821 | 123364 | 30841 |
| Total Current Assets | 169604 | 163032 | 182991 | 253045 | 180079 |
| Creditors | 19846 | 15027 | 27334 | 32373 | 42843 |
| Short Term Borrowing | 34732 | 66578 | 78184 | 122247 | 60547 |
| Other Current Liabilities | 38218 | 49312 | 47258 | 65061 | 78073 |
| Total Current Liabilities | 92796 | 130917 | 152776 | 219681 | 181463 |
| Net Current Assets | 76808 | 32115 | 30215 | 33364 | -1384 |
| Shareholders Funds | 320924 | 580157 | 732019 | 767315 | 881420 |
| Total Loan Capital | 8838 | 7158 | 14817 | 10309 | 10309 |
| Other Capital Employed | 27451 | 83737 | 132422 | 141080 | 169296 |
| Total Capital Employed | 357213 | 671052 | 879258 | 918704 | 1061025 |
| Pretax Profit Margin % | 4.17 | 3.33 | 22.15 | 35.25 | 40.02 |
| Sales Growth % | 39 | 12 | 8 | 13 | 15 |
| Pretax Profit Growth % | 88 | -10 | 619 | 79 | 30.67 |
| Debtor Ratio Days | 69 | 73 | 63 | 68 | 68.4177757843212 |
| Creditor Ratio Days | 18 | 12 | 21 | 22 | 25.1163258535464 |
| Stock Turnover | 18 | 15 | 20 | 19 | 19.0867058157634 |
| Sales £000 / Employee | 702 | 778 | 824 | 953 | 1048.58180212014 |
| Value Added £000/Empl. | 162 | 170 | 172 | 182 | 580.803806747689 |
| Av. Remun. £000 / Empl. | 118 | 124 | 116 | 126 | 125.556537102473 |
| Total Empl. Remu. £000 | 66371 | 70780 | 67501 | 71065 | 74347.2281440589 |
| Employees | 562 | 570 | 582 | 566 | 592.141435721347 |
| Pretax Profit/Total Assets % | 4 | 2 | 10 | 17 | 20 |
Company Summary
- The Plimsoll Chart is falling though its height is ok.
- Total Sales have increased by 12.6% in the latest year, well above the industry average of 10.5%.
- Sales per Employee is £953,000 which is well above the industry average of £424,000.
- The average salary is £126,000 which is well above the industry average of £60,000.
- The company is ranked among the fastest growing in terms of sales growth in the latest year.
- Pretax Profit Margin is 35.2% in the latest year, well above the industry average of 12.1%.
- Pretax Profit Margin has markedly improved from 22.1% to 35.2% in the latest year.
- Shareholders received £152.0m in dividends this year, over 80% of the pretax profits of the company.
- Non Trading Income of £176.0m makes a large contribution to pretax profits of £190.2m.
- The formal debt of the company is high, representing 25% of Total Sales.
- Formal debt of the company has increased by £39.6m, a rise of 43%.
- The Trading Stability chart shows a well below average sales return on total assets in the latest year
- The company is among the Top 3 companies listed as a Best Trading Partner (see section 1c).
- The company is among the Top 4 Leaders in Efficiency.
Company Summary
The company currently has £540m sales and made £190m, by following the proposal plan, sales would rise to £621m and profits would rise to £248m.
Key Attractiveness Features
- ADD £540m TO SALES
- ATTRACTIVE PRICE
- FEW DIRECTORS
- HIGH DIVIDEND
Acquisition Attractiveness Rating
- Low number of shareholders
- Company is privately owned
- Low number of directors
- Sales growth above the industry average
- Low financial rating
- High gross earnings
- Big difference between current and future value
- Directors fees represent high proportion of profits
- Average age of directors is high
Company Valuation
| Proposed Year |
|||||
|---|---|---|---|---|---|
| Period Ending | 31-Dec-20 | 31-Dec-21 | 31-Dec-22 | 31-Dec-23 | 29-Dec-24 |
| Total Sales (£000) | 394395 | 443189 | 479308 | 539543 | 620909 |
| Pre-tax Profit (£000) | 16434 | 14761 | 106150 | 190175 | 248498 |
| Total Value (£000) | 451865 | 828493 | 1033498 | 1101311 | 2472527 |
| Asset Value (£000) | 377150 | 757408 | 956213 | 1015021 | 1211647 |
| Goodwill (£000) | 74715 | 71085 | 77285 | 86290 | 1260880 |
| Liabilities (£000) | -56226 | -177251 | -224194 | -247706 | -330227 |
| Equity Value (£000) | 395639 | 651242 | 809304 | 853605 | 2142300 |
Total Value Formula: (Pretax Profit + Interest Payments - Non Trading Income + Directors Fees) * 5 plus (Fixed Assets + Intangibles + Intermediate Assets + Stocks + Debtors)
Shareholders / Ownership
ABBOTT (UK) HOLDINGS LTD
Immediate Shareholder: See Shareholders
Subsidiaries
ABBOTT DIABETES CARE LTD
ABBOTT LABORATORIES TRUSTEE COMPANY LTD
LINGO TECHNOLOGY UK LTD
MUREX BIOTECH LTD
ABBOTT MEDICAL U.K. LTD
ABBOTT UK SUBSIDIARY LTD
Acquisition / Valuation Comments
This company has been established 88 years.
The number of shareholders is low (1)
The value of the company has risen in each of the last 2 years.
The value of the company has fluctuated in the last 2 years.
The total value of the company is currently £1.1bn including debts.
The equity value is high, indicating low levels of total liabilities.
The proposed year is based on achieving a 20% return on total assets.
The company's value would increase by 125% if the proposed business plan was followed.
The proposed plan would improve the overall financial strength of the company by 17%.
Book a FREE no obligation demo with one of our specialists to see how Plimsoll can help you
Book a free Demo